secwatch.observer — SEC 8-K summary
======================================

Issuer:     EXAGEN INC. (XGN)
CIK:        0001274737
Form:       8-K
Filed at:   2022-12-05T23:59:59+00:00
Accession:  0001274737-22-000080
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 2.05, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Exagen reduces workforce by 42, estimates $750k in Q4 charges; CMO terminated
-----------------------------------------------------------------------------

- Board approved reduction in force of 42 employees, completed Dec 5, 2022, to conserve cash.
- Estimated pre-tax charges of ~$750k in Q4 2022 for severance, benefits, and related costs.
- CMO Debra Zack terminated; entitled to lump sum of ~$201.6k (6 months salary) plus COBRA reimbursement.
- Dr. Zack entered consulting agreement at $250/hr through Mar 31, 2023; unvested stock options continue to vest.
- COO Mark Hazeltine appointed Chief Business Officer, effective Dec 5, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1274737/000127473722000080/0001274737-22-000080-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1274737/000127473722000080/exdx-20221205.htm
  HTML page:      https://secwatch.observer/filing/0001274737-22-000080

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer